Form 8-K - Current report:
SEC Accession No. 0001654954-26-002338
Filing Date
2026-03-17
Accepted
2026-03-17 17:19:23
Documents
14
Period of Report
2026-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbsv_8k.htm   iXBRL 8-K 24625
2 PRESS RELEASE pbsv_ex991.htm EX-99.1 7050
  Complete submission text file 0001654954-26-002338.txt   135617

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbsv-20260317.xsd EX-101.SCH 5022
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbsv-20260317_lab.xml EX-101.LAB 12568
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbsv-20260317_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbsv-20260317_pre.xml EX-101.PRE 7857
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbsv-20260317_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT pbsv_8k_htm.xml XML 2910
Mailing Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646
Business Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646 787-278-2709
Pharma-Bio Serv, Inc. (Filer) CIK: 0001304161 (see all company filings)

EIN.: 200653570 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-50956 | Film No.: 26763515
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)